# Parita Shah

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/parita-shah/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,513 |
| Field | Schizophrenia research and treatment |
| h-index | 21 |
| i10-index | 30 |
| Last Known Institution | Hindu College of Pharmacy |
| OpenAlex ID | https://openalex.org/A5103058310 |
| ORCID iD | 0000-0002-7302-0411 |
| Works | 63 |

## Researcher papers

- [COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study](https://scholariq.org/papers/covid-19-vaccine-induced-antibody-responses-in-immunosuppressed-patients-with/)
- [Insight and medication adherence in schizophrenia: An analysis of the CATIE trial](https://scholariq.org/papers/insight-and-medication-adherence-in-schizophrenia-an-analysis-of-the-catie-trial/)
- [Glutamatergic Neurometabolite Levels in Patients With Ultra-Treatment-Resistant Schizophrenia: A Cross-Sectional 3T Proton Magnetic Resonance Spectroscopy Study](https://scholariq.org/papers/glutamatergic-neurometabolite-levels-in-patients-with-ultra-treatment-resistant/)
- [Sertraline response in adults with mental retardation and autistic disorder.](https://scholariq.org/papers/sertraline-response-in-adults-with-mental-retardation-and-autistic-disorder/)
- [The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: A systematic review](https://scholariq.org/papers/the-impact-of-delay-in-clozapine-initiation-on-treatment-outcomes-in-patients/)
- [COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study](https://scholariq.org/papers/covid-19-vaccine-induced-antibody-and-t-cell-responses-in-immunosuppressed/)
- [A meta-analysis of transcranial direct current stimulation for schizophrenia: “Is more better?”](https://scholariq.org/papers/a-meta-analysis-of-transcranial-direct-current-stimulation-for-schizophrenia-is/)
- [Validation of PI-RADS Version 2 in Transition Zone Lesions for the Detection of Prostate Cancer](https://scholariq.org/papers/validation-of-pi-rads-version-2-in-transition-zone-lesions-for-the-detection-of/)
- [Fixed-dose combination in management of type 2 diabetes mellitus: Expert opinion from an international panel](https://scholariq.org/papers/fixed-dose-combination-in-management-of-type-2-diabetes-mellitus-expert-opinion/)
- [Clozapine response trajectories and predictors of non-response in treatment-resistant schizophrenia: a chart review study](https://scholariq.org/papers/clozapine-response-trajectories-and-predictors-of-non-response-in-treatment/)
- [Lead (Pb) in Alzheimer’s Dementia: A Systematic Review of Human Case- Control Studies](https://scholariq.org/papers/lead-pb-in-alzheimer-s-dementia-a-systematic-review-of-human-case-control/)

## Researcher topics

- [Schizophrenia research and treatment](https://scholariq.org/topics/schizophrenia-research-and-treatment/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Bipolar Disorder and Treatment](https://scholariq.org/topics/bipolar-disorder-and-treatment/)
- [Mental Health and Psychiatry](https://scholariq.org/topics/mental-health-and-psychiatry/)
- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)

## Researcher university

- [Hindu College of Pharmacy](https://scholariq.org/institutions/hindu-college-of-pharmacy/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.